会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Device For Fluorescence Diagnosis
    • 荧光诊断装置
    • US20120248333A1
    • 2012-10-04
    • US13430174
    • 2012-03-26
    • Johannes FallertPeter SchwarzWerner GoebelAndre EhrhardtKlaus-Martin Irion
    • Johannes FallertPeter SchwarzWerner GoebelAndre EhrhardtKlaus-Martin Irion
    • G01N21/64
    • G01N21/6456A61B1/00186A61B1/0638A61B1/0646G01N2021/6471
    • A diagnosis device having an illumination system configured to produce white light along an illumination path, an observation system for observing the target region in a white-light and fluorescence mode, the observation system having an observation path having at least one first image sensor for receiving a white-light image and at least one second image sensor for receiving a fluorescence image, an observation spectral filter in the observation path are configured such that light in the spectral range of the fluorescence can be fed to the second image sensor while light in the spectral ranges outside of the fluorescence is blocked. An illumination spectral filter is arranged in the illumination path and having a characteristic of the observation spectral filter such that the target region is illuminated with the whole spectral range of the white light with the exception of the spectral range of the fluorescence to be observed.
    • 一种具有照明系统的诊断装置,被配置为沿着照明路径产生白光,观察系统用于以白光和荧光模式观察所述目标区域,所述观察系统具有观察路径,所述观察路径具有至少一个用于接收的第一图像传感器 白光图像和用于接收荧光图像的至少一个第二图像传感器,观察路径中的观察光谱滤波器被配置为使得荧光的光谱范围内的光可以被馈送到第二图像传感器,同时在 荧光外的光谱范围被阻断。 照明光谱滤光器布置在照明路径中,并且具有观察光谱滤波器的特性,使得除了要观察的荧光的光谱范围之外,白色光的整个光谱范围被照射目标区域。
    • 6. 发明授权
    • Dry end
    • 干端
    • US5987777A
    • 1999-11-23
    • US091715
    • 1998-09-09
    • Werner GoebelKarlheinz Straub
    • Werner GoebelKarlheinz Straub
    • D21F5/04D21G9/00F26B3/00D21F5/00
    • D21G9/0063D21F5/042
    • The invention relates to a dry end for drying a material web, in particular a paper or cardboard web, having at least one drying group with a plurality of drying cylinders and web guiding rollers and at least one nozzle device for transporting the threading part of the material web along a winding path by means of at least one conveyor band. The dry end is characterised in that groups of at least two nozzle devices (17, 19, 21) located at the same side of the material web (11) follow each other in the direction of transport of the material web (11).
    • PCT No.PCT / EP96 / 05798 371 1998年9月9日第 102(e)1998年9月9日PCT PCT 1996年12月21日PCT公布。 公开号WO97 / 23690 日期1997年7月3日本发明涉及用于干燥材料纤维网,特别是纸或纸板幅材的干燥端,其具有至少一个具有多个干燥筒和幅材引导辊的干燥组和至少一个用于输送的喷嘴装置 通过至少一个传送带,沿着卷绕路径的材料卷材的穿线部分。 干端的特征在于,位于材料纤维网(11)的同一侧的至少两个喷嘴装置(17,19,21)的组在材料纤维网(11)的输送方向上彼此相邻。
    • 8. 发明申请
    • Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
    • 微生物作为编码用于治疗肿瘤的细胞抗原的核苷酸序列的载体
    • US20060105423A1
    • 2006-05-18
    • US10506096
    • 2003-02-13
    • Ulf RappWerner GoebelIvaylo GentschevJoachim Fensterle
    • Ulf RappWerner GoebelIvaylo GentschevJoachim Fensterle
    • C07K14/195C07K14/245C07H21/04C12P21/06C12N15/74C12N1/21
    • C12N9/1205A61K39/00A61K39/0011A61K2039/523A61K2039/53C07K14/255C07K14/4748C07K2319/02C12R1/42
    • The invention relates to a microorganism with a nucleotide sequence coding for a cell antigen in which the following components are inserted and are expressible: I) a nucleotide sequence coding for at least one epitope of an antigen of a tumor cell and/or a nucleotide sequence for at least one epitope of an antigen that is specific for a tissue cell from which the tumor originates; II) an optional nucleotide sequence coding for a protein that stimulates cells of the immune system; IIIA) a nucleotide sequence for a transport system which makes it possible to express the expression product of components I) and, optionally, II) on the outer surface of the bacterium and/or secrete the expression product of component I) and, optionally, of component II); and/or IIIB) a nucleotide sequence for a protein used for lysing the microorganisms in the cytosol of mammalian cells and for intracellularly releasing plasmids which are contained in the lysed microorganisms; and IV) an activation sequence for expressing one or several of components I) to IIIB), said activation sequence being selected among the group consisting of an activation sequence which is capable of being activated in the microorganism, is tissue-cell-specific but not cell-specific. Each of components I) to IV) can be identically or differently arranged in an individual or multiple manner. Also disclosed are uses of such a microorganism for the production of a medicament.
    • 本发明涉及具有编码细胞抗原的核苷酸序列的微生物,其中插入以下组分并且是可表达的:I)编码肿瘤细胞抗原和/或核苷酸序列的至少一个表位的核苷酸序列 对于来自肿瘤的组织细胞特异性的抗原的至少一个表位; II)编码刺激免疫系统细胞的蛋白质的任选的核苷酸序列; IIIA)用于运输系统的核苷酸序列,其使得可以在细菌的外表面上表达组分I)和任选的II)的表达产物和/或分泌组分I)的表达产物,并且任选地, 的组分II); 和/或IIIB)用于裂解哺乳动物细胞的细胞质中的微生物和细胞内释放裂解微生物中所含质粒的蛋白质的核苷酸序列; 和IV)用于表达组分I)至IIIB)中的一种或几种的活化序列,所述活化序列选自能够在微生物中活化的活化序列是组织细胞特异性但不是组织细胞特异性 细胞特异性 组件I)至IV中的每一个)可以以单独或多种方式相同或不同地布置。 还公开了这种微生物用于制备药物的用途。
    • 10. 发明申请
    • Anti-infectious carbohydrates
    • 抗感染性碳水化合物
    • US20050004070A1
    • 2005-01-06
    • US10490102
    • 2002-09-25
    • Bernd StahlBerndt FinkeJoachim SchmittWerner GoebelJorg Slaghuis
    • Bernd StahlBerndt FinkeJoachim SchmittWerner GoebelJorg Slaghuis
    • A61K31/702A61K31/715A61P31/00A61K31/739C08B37/00
    • A61K31/702A61K31/715
    • Neutral straight-chain or branched oligosaccharides for preventing the invasion and infection of mammal cells by pathogens and for fighting diseases caused by such pathogens are disclosed. Food, dietetic products and pharmaceutical agents containing oligosaccharides consist of a base unit of formula (I), and between 0 and 19 other units of formula (II), which are linked directly or indirectly to the base unit. Gal represents a galactose monosaccharide unit; Glc represents a glucose monosaccharide unit; HexNAc rpresents an N-acetylated galactosamine or glucosamine monosaccharide unit (GalNAc or GlcNAc); R independently represent a β 1-3 or β 1-6 glycosidic link to HexNAc monosaccharide of the next [Gal-HexNAc] unit (II), and on a terminal [Gal-HexNAc] unit, or R are not present; and a terminal [Gal-HexNAc] unit, wherein R represent a deoxyhexose radical, can have another deoxyhexose radical on the HexNAc monosaccharide unit.
    • 公开了用于防止病原体侵染和感染哺乳动物细胞并用于与这种病原体引起的疾病的中性直链或支链寡糖。 含有寡糖的食品,饮食产品和药剂由式(I)的基本单元和0至19个式(II)的其它单元直接或间接连接到基础单元组成。 Gal代表半乳糖单糖单位; Glc表示葡萄糖单糖单元; HexNAc表示N-乙酰化的半乳糖胺或葡糖胺单糖单元(GalNAc或GlcNAc); R独立地表示与下一个[Gal-HexNAc]单元(II)的HexNAc单糖的β1-3或β1-6糖基连接,并且在末端[Gal-HexNAc]单元上,或R不存在; 和末端[Gal-HexNAc]单元,其中R表示脱氧己糖基团,可以在HexNAc单糖单元上具有另一脱氧己糖基团。